Todos Medical Stock News

Todos Medical Ltd. (OTCQB:TOMDF) revealed that its Provista Diagnostics business has now commercially launched its PCR-based MonkeyPox test in the US in a bid to join the battle to contain the virus.

Todos Medical Ltd. (OTCQB:TOMDF) said its majority-owned subsidiary 3CL Pharma Ltd has finished plans for a proposed safety and efficacy clinical trial for its 3CL protease inhibitor immune support di

Todos Medical Ltd. (OTCQB:TOMDF) said its majority-owned subsidiary 3CL Pharma Ltd has finished plans for a proposed safety and efficacy clinical trial for its 3CL protease inhibitor immune support di

Todos Medical Ltd announced that its CLIA/CAP-certified laboratory Provista Diagnostics has completed validation of its PCR-based Wound and Respiratory Pathogen panels.  The Wound Panel (WP) is a 31-

Todos Medical Ltd. (OTCQB:TOMDF) said its clinical testing laboratory Provista Diagnostics has entered into two contracts to provide PCR-based monkeypox testing.

Todos Medical Ltd revealed that the first commercial patient samples have been received for its Long COVID Panel biomarker partnership between its CLIA/CAP certified lab Provista Diagnostics and Ameri

§  Lesion swab (standard of care) and saliva-based sample collection planned §  Peer-reviewed publication demonstrating saliva testing sensitivity opens door for asymptomatic testing New York, NY, and Tel Aviv, Israel -- Aug. 03, 2022 -- InvestorsHub NewsWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP-certified laboratory Provista Diagnostics...

Todos Medical Ltd. (OTCQB:TOMDF) is set to branch into the world of MonkeyPox testing through its subsidiary Provista Diagnostics Inc, which has started a validation plan for PCR-based testing.

Todos Medical Ltd has said that its majority-owned joint venture 3CL Pharma Ltd has once again highlighted the case for its oral dietary supplement Tollovid, pointing to a pre-print in ResearchGate o

Todos Medical Ltd. (OTCQB:TOMDF) announced that its CLIA/CAP certified clinical laboratory Provista Diagnostics has entered into an agreement with Amerimmune Diagnostics, a CLIA/CAP certified laborato

Todos Medical Ltd reported positive results in the use of the medication Paxlovid and dietary supplement Tollovid in the treatment of a patient with long COVID. Comprehensive medical diagnostics and

Todos Medical Ltd. (OTCQB:TOMDF) has announced biomarker data from its majority-owned joint venture 3CL Pharma Ltd's Phase 2 clinical trial of Tollovir in hospitalized COVID-19 patients, along with pl

Todos Medical Ltd has announced preliminary data from a sponsored market research study on the commercial use of Tollovid as a dietary supplement among people with coronavirus (COVID-19).  The instit

Todos Medical Ltd has said it is preparing for the commercial launch of a urinary tract infection (UTI) PCR assay after its lab Provista Diagnostics completed validation of a 27-pathogen precision me

Todos Medical Ltd's majority-owned subsidiary 3CL Pharma Ltd has provided a Day 45 update from its ongoing case study of Tollovid, a 3CL protease inhibitor dietary supplement, for a patient with long